Neil Moat of The Royal Brompton Hospital in London, United Kingdom, reviews the technologies currently being developed for transcatheter mitral valve repair and replacement.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter Mitral Intervention
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation. A Global Feasibility Trial
January 27, 2017
Results are reported of a global feasibility study in which 30 patients at high risk for mitral valve surgery were enrolled at 8 study sites. Patients underwent transapical mitral valve replacement with a Tendyne transcatheter mitral valve. A mitral prosthesis was successfully implanted in 93%.
Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry
July 25, 2016
The authors describe their findings in a multicenter retrospective review of clinical outcomes in 64 patients with severe mitral annular calcification considered poor candidates for traditional surgical mitral valve replacement, undergoing transcatheter mitral valve implantation with a balloon expandable prosthesis.
June 11, 2016
The authors summarize currently available catheter-based treatments for mitral regurgitation. The options are numerous and are evolving rapidly. Commentary: http://www.jtcvsonline.org/article/S0022-5223%2816%2930318-X/fulltext
Echocardiographic Essentials: From Screening to Device Implantation- What the Interventional Cardiologist Needs to Know
March 28, 2016
A refreshing , adequately supported by pragmatic imaging, 22 minute presentation from an Arizona meeting that many surgeons would find quite informative and educating. Dr.
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial
December 10, 2015
The study was a single-arm, multicentre, prospective study enrolling 31 high-risk adult individuals with symptomatic mitral regurgitation despite optimal medical therapy from five institutions in Europe. The primary efficacy endpoints included: (a) Technical success rate of the device implantation; (b) Technical feasibility of Cardioband adjustment;
September 29, 2015
Vinnie Bapat of Guys and St. Thomas’ Hospital, London, UK, discusses the Edwards FORTIS device, a transcatheter mitral valve device.
September 24, 2015
Neil Moat of the Royal Brompton Hospital, London, UK, gives a talk on transcatheter mitral valve implantation.
September 15, 2015
Alec Vahanian of Bichat Hospital, Paris, France, provides an overview of transcatheter mitral valve repair.
August 26, 2015
Vinod Thourani, Michael Mack, Wilson, Szeto, Eric Roselli, and Gorav Ailawadi discuss percutaneous mitral valve repair at the 2015 STS Annual Meeting.